Planta Med 2002; 68(8): 690-693
DOI: 10.1055/s-2002-33806
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Potentiation of Vasoconstrictor Response and Inhibition of Endothelium-Dependent Vasorelaxation by Gallic Acid in Rat Aorta

Fujiko Sanae1 , Yukinori Miyaichi2 , Hisao Hayashi1
  • 1Department of Medicine, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
  • 2Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
Weitere Informationen

Publikationsverlauf

Received: October 11, 2001

Accepted: March 17, 2002

Publikationsdatum:
09. September 2002 (online)

Abstract

In the isolated rat thoracic aorta, gallic acid potentiated the vasoconstrictor response to phenylephrine. The potentiation produced by gallic acid was absent in endothelium-denuded arteries. The potentiation was abolished by N G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, and slightly attenuated by an addition of L-arginine, while indomethacin or BQ610 had no effect. The potentiation of response to phenylephrine was not found for structural modifications of gallic acid, except for caffeic acid. Gallic acid also inhibited vasorelaxation induced by acetylcholine, sodium nitroprusside or prostacyclin, especially that by acetylcholine. The effect on vasorelaxation induced by acetylcholine was decreased by esterification of the carboxy group of gallic acid, and in the absence or by the methylation of the o-dihydroxy group. Caffeic acid inhibited the vasorelaxation, though the effect was smaller than that of gallic acid. These findings indicate that gallic acid produces a potentiation of contractile response and inhibition of vasorelaxant responses, probably through inactivation of nitric oxide (NO), in which endothelially produced NO is principally involved, and that the modification of functional groups of the gallic acid molecule abolishes the potentiation of contractile response and attenuates the inhibition of vasorelaxant responses.

References

  • 1 Moncada S, Palmer R MJ, Gryglewski R J. Mechanism of action of some inhibitors of endothelium-derived relaxing factor.  Proc Natl Acad Sc USA. 1986;  83 9164-8
  • 2 Nussler A K, Billiar T R. Inflammation, immunoregulation, and inducible nitric oxide synthase.  J Leuk Biol. 1993;  54 171-8
  • 3 Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol.  Life Sci. 1997;  53 576-82
  • 4 Kroes B H, van den Berg A J, Quarles van Ufford H C, van Dijk H, Labadie R P. Anti-inflammatory activity of gallic acid.  Planta Medica. 1992;  58 499-504
  • 5 Sakagami H, Satoh K, Hatano T, Yoshida T, Okuda T. Possible role of radical intensity and oxidation potential for gallic acid-induced apoptosis.  Anticancer Res. 1997;  17 377-80
  • 6 Miyase T, Ishino M, Akahori C, Ueno A, Ohkawa Y, Tanizawa H. Phenylethanoid glycosides from Plantago asiatica .  Phytochemistry. 1991;  30 2015-8
  • 7 Ignarro L J, Byrns R E, Buga G M, Wood K S, Chaudhuri G. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.  J Pharmacol Exp Ther. 1987;  244 181-9

Fujiko Sanae Ph D

Department of Medicine

Faculty of Pharmaceutical Sciences

Hokuriku University


Ho-3, Kanagawa

Kanazawa 920-1181

Japan

eMail: f-sanae@hokuriku-u.ac.jp

Fax: +81-76-229-6205

    >